QMS Medical Allied Services
- Market cap
- ₹ 334 Cr.
- P/E
- 32x
- P/B
- 3.26x
- 52-week range
- 68.95 – 216.79
- ROE
- 10%
- ROCE
- 13%
- Dividend yield
- 0.3%
- Debt / equity
- 0.71
- Sector
- Healthcare Equipment & Supplies
- Industry
- Medical Equipment & Supplies
- Listed on
- NSE
About
QMS Medical Allied Services Limited is an India-based healthcare company specializing in patient screening services and the supply of advanced diagnostic medical devices. Through its Patient Service Programs (PSP), the Company provides patients nationwide with access to critical diagnostic tests for conditions such as osteoporosis, diabetes mellitus, chronic obstructive pulmonary disease, and hypertension. The Company’s segment is Healthcare Equipments/Supplies & Services. The Company’s products include B2B Sales, E-Commerce and Point of Care. Its services include Patient Service Programs and Educamedics. The Company distributes products from various companies as well as its own brand, Q Devices. Its comprehensive solutions for patient care include tele counseling, in clinic activation, advanced respiratory screening programs, and orthopedic screening and wellness programs. Educamedics is a division of the Company offering customized solutions in the field of scientific education.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Medical Equipment & Supplies: 25 companies →QMS Medical Allied Services against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)32 against a typical 28.7: pricier than most peers (1st = cheapest).14th of 25
- Sales growth+22.3% against a typical +21.5% from a year earlier.9th of 18
- Profit growth+25.3% against a typical +13.4% from a year earlier.5th of 16
- Share price, 3 months+52.1% against a typical −7.9%.2nd of 23
- Size₹ 334.1 Cr. market value against a typical ₹ 238.1 Cr. (1st = largest).11th of 24
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 14 Aug 2026 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2026 |
| 30 May 2026 | Financial Results/Dividend/Other business matters | To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters |
| 14 Feb 2026 | Board Meeting Intimation | QMS MEDICAL ALLIED SERVICES LIMITED has informed the Exchange about Board Meeting to be held on 14-Feb-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2025 . |
| 13 Nov 2025 | Financial Results | To consider and approve the financial results for the period ended September 30, 2025 |
| 29 Aug 2025 | Fund Raising | In compliance with Regulation 29(1)(d) and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations"), we hereby inform you that a meeting of the Board of Directors of QMS Medical Allied Services Limited ("the Company") is scheduled to be held on Friday, August 29, 2025, to inter-alia, consider and decide on various matters in connection with aforesaid Rights Issue such as determination of Issue price, Rights Entitlement ratio, Record Date and other terms and conditions with respect to the Rights Issue, subject to the receipt of in-principle approval from the stock exchanges where the securities of the Company are listed or such other regulatory authorities as may be required. |
| 22 Aug 2025 | Fund Raising | To consider Fund Raising |
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Dec 2023 | Mar 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 35 | 32 | 37 | 44 | 45 | 47 | 45 | 37 | 44 | 57 |
| Expenses | 30 | 28 | 30 | 37 | 38 | 40 | 38 | 31 | 39 | 49 |
| Operating Profit | 5 | 4 | 7 | 7 | 6 | 7 | 7 | 7 | 6 | 8 |
| OPM % | 13.7% | 12.2% | 19.5% | 15.8% | 14.3% | 14.1% | 15.5% | 18.1% | 13.3% | 14.6% |
| Other Income | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | 3 | 2 | 6 | 5 | 5 | 4 | 5 | 4 | 3 | 6 |
| Tax % | 25.8% | 29.7% | 25.3% | 30.2% | 23.2% | 29.6% | 26.2% | 25.7% | 29.2% | 28.7% |
| Net Profit | 2 | 2 | 4 | 3 | 4 | 3 | 4 | 3 | 2 | 4 |
| EPS in Rs | 1.26 | 0.8 | 1.78 | 1.51 | 1.73 | 1.52 | 1.61 | 1.24 | 0.82 | 1.89 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- —
- 5 Years
- —
- 3 Years
- —
- TTM
- 6%
- 10 Years
- —
- 5 Years
- —
- 3 Years
- —
- TTM
- −15%
- 10 Years
- —
- 5 Years
- —
- 3 Years
- 0%
- TTM
- —
- 10 Years
- —
- 5 Years
- —
- 3 Years
- 12%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| QMS Medical Allied Services | ₹ 177.00 | ₹ 334 Cr. | 32x | 3.3x | 10% | — |
| Lenskart Solutions | ₹ 627.55 | ₹ 1,08,959 Cr. | 188.5x | 11.1x | 6.7% | 5.7% |
| Poly Medicure | ₹ 1,446.80 | ₹ 14,582 Cr. | 51.9x | 5.5x | 11% | 17.1% |
| Laxmi Dental | ₹ 171.25 | ₹ 946 Cr. | 35.1x | 4.9x | 12.8% | 9.5% |
| One Global Service Provider | ₹ 372.00 | ₹ 721 Cr. | 16.9x | 8.3x | 65.2% | 14% |
| Mallcom (India) | ₹ 909.00 | ₹ 567 Cr. | 20.9x | 2x | 9.7% | 5.6% |
Management
- Mahesh Pahalraj Makhija
- Chairman of the Board, Managing Director
- Sejal Vivek Mhatre
- Chief Financial Officer
- Toral Jailesh Bhadra
- Company Secretary and Compliance Officer
Prices are delayed and for information only. Nothing on this page is investment advice.